The impact of MRSA infection in the airways of children with Cystic Fibrosis; a case-control study

Irish Medical Journal

Volumn 104, Issue 10, 2011, Pages 1-4

  Cox, D W ^a   Kelly, C ^b   Rush, R ^b   O'Sullivan, N ^b   Canny, G ^b   Linnane, B ^b  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^b Princess Margaret Hospital   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE DURATION; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INFECTION RISK; LUNG FUNCTION; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PATIENT ASSESSMENT; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; RISK FACTOR; SCHOOL CHILD;

EID: 84858374238     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Rosenstein BJ, Zeitlin PL. Cystic fibrosis. Lancet. 1998 Jan 24;351:277-282.
2. Cystic Fibrosis Foundation Patient Registry Annual Data Report 2005. Cystic Fibrosis Foundation 2006. report; 2006.
3. Littlewood. Cystic Fibrosis. 2007. p. 3-19.
4. Razvi S, Quittell L, Sewall A, Quinton H, Marshall B, Saiman L. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. Chest. 2009 Dec;136:1554-1560.
5. Miall LS, McGinley NT, Brownlee KG, Conway SP. Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis. Arch Dis Child. 2001 Feb;84:160-162.
6. Solis A, Brown D, Hughes J, Van Saene HK, Heaf DP. Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol. Pediatr Pulmonol. 2003 Sep;36:189-195.
7. Thomas SR, Gyi KM, Gaya H, Hodson ME. Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre. J Hosp Infect. 1998 Nov;40(3):203-209.
8. Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med. 2008 Oct 15;178:814-821.
9. Elizur A, Orscheln RC, Ferkol TW, Atkinson JJ, Dunne WM, Jr., Buller RS, Armstrong JR, Mardis ER, Storch GA, Cannon CL. Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest. 2007 Jun;131:1718-1725.
10. Ren CL, Morgan WJ, Konstan MW, Schechter MS, Wagener JS, Fisher KA, Regelmann WE; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol. 2007 Jun;42:513-518.
11. Sawicki GS, Rasouliyan L, Pasta DJ, Regelmann WE, Wagener JS, Waltz DA, Ren CL. The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis. Pediatr Pulmonol. 2008 Nov;43:1117-1123.
12. Zapletal A, Paul T, Samanek M. [Significance of contemporary methods of lung function testing for the detection of airway obstruction in children and adolescents (author's transl)]. Z Erkr Atmungsorgane. 1977 Aug;149:343-371.
13. Wigglesworth N, Wilcox MH. Prospective evaluation of hospital isolation room capacity. J Hosp Infect. 2006 Jun;63:156-161.
14. Dziekan G, Hahn A, Thune K, Schwarzer G, Schafer K, Daschner FD, Grundmann H. Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study. J Hosp Infect. 2000 Dec;46:263-270.
15. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother. 2002 Jun;49:999-1005.
16. LeBlanc L, Pepin J, Toulouse K, Ouellette MF, Coulombe MA, Corriveau MP, Alary ME. Fluoroquinolones and risk for methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis. 2006 Sep;12:1398-1405.
17. Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA. 2010 Jun 16;303:2386-2392.
18. Garske LA, Kidd TJ, Gan R, Bunting JP, Franks CA, Coulter C, Masel PJ, Bell SC. Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection. J Hosp Infect. 2004 Mar;56:208-214.
19. Macfarlane M, Leavy A, McCaughan J, Fair R, Reid AJ. Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol. J Hosp Infect. 2007 Mar;65:231-236.